Novel Adjuvants and Delivery Systems for Vaccines
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Adjuvants".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 1014
Special Issue Editors
Interests: vaccines; drug development; adjuvants; nanoparticle; quorum sensing; antibiotics; pre-clinical research
Interests: vaccine delivery; microneedle based vaccine delivery; vaccine delivery using oral dissolving films
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Novel adjuvants and delivery systems for vaccines improve the quality of vaccine production by enhancing the immune response to a vaccine. Adjuvants can strengthen the immune system's response to the vaccine. Adjuvants have been traditionally used to increase the magnitude of the antibody response to a vaccine based on antibody titer or the ability to prevent infection and can guide the type of adaptive response to produce the most effective form of immunity. It is important to consider the construction of vaccine adjuvant delivery systems for both adjuvant activity and antigen delivery. In this Special Issue, we will explore prospective novel adjuvant approaches to modify innate and adaptive immune responses to ease the development of enhanced prophylactic or therapeutic vaccines. We welcome contributions to vaccine adjuvant advances, immune enhancement mechanisms, rational design, immunostimulatory molecules, emulsions, liposomes, virosomes, and polymers with functional molecules.
Dr. Christiane Chbib
Dr. Mohammad N. Uddin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- drug development
- adjuvants
- nanoparticle
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
